The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.50
Bid: 50.30
Ask: 50.40
Change: 1.45 (2.96%)
Spread: 0.10 (0.199%)
Open: 47.20
High: 50.70
Low: 47.20
Prev. Close: 49.05
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

27 Jan 2022 07:00

RNS Number : 7703Z
IP Group PLC
27 January 2022
 

 

 

 

 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

26-Jan-22

Number of ordinary shares purchased:

445,556

Highest price paid per ordinary share (GBp):

 99.40

Lowest price paid per ordinary share (GBp):

 97.10

Volume weighted average price paid per ordinary share (GBp):

97.9342

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 28,696,656 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,034,336,631, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

26 January 2022

Number of ordinary shares purchased:

445,556

Volume weighted average price (pence):

97.9342

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

9300

97.50

 08:19:44

LSE

92

97.50

 08:19:44

LSE

1

98.40

 09:04:45

LSE

2737

99.40

 09:52:28

LSE

266

99.40

 09:52:28

LSE

6329

99.40

 09:52:28

LSE

557

99.10

 10:00:33

LSE

9200

99.10

 10:00:33

LSE

815

98.50

 11:18:10

LSE

3000

98.50

 11:18:10

LSE

1127

98.30

 11:59:18

LSE

2636

98.40

 12:02:00

LSE

5800

98.40

 12:02:00

LSE

350

98.40

 12:02:00

LSE

9601

97.90

 12:04:00

LSE

9202

98.00

 13:36:12

LSE

10328

98.00

 14:04:18

LSE

3000

98.10

 14:33:09

LSE

9699

98.00

 14:33:47

LSE

627

98.00

 14:33:47

LSE

2749

98.20

 14:52:38

LSE

845

98.20

 14:57:25

LSE

517

98.50

 15:06:26

LSE

259

98.50

 15:06:31

LSE

183

98.50

 15:06:35

LSE

1372

98.50

 15:07:54

LSE

8418

98.30

 15:16:11

LSE

1209

98.30

 15:16:11

LSE

290

98.00

 15:29:01

LSE

693

98.00

 15:29:01

LSE

396

98.00

 15:31:06

LSE

315

98.00

 15:31:06

LSE

8924

98.00

 15:44:37

LSE

2472

97.90

 15:58:19

LSE

6701

97.90

 15:58:19

LSE

300000

97.85

 16:02:15

LSE

1085

97.90

 16:02:51

LSE

888

97.90

 16:02:51

LSE

557

98.00

 16:07:41

LSE

1425

98.00

 16:07:41

LSE

1098

98.00

 16:07:41

LSE

40

98.00

 16:07:41

LSE

450

97.80

 16:15:33

LSE

2108

97.70

 16:17:14

LSE

2065

97.70

 16:17:14

LSE

3098

97.70

 16:17:14

LSE

1900

97.70

 16:17:14

LSE

709

97.70

 16:17:14

LSE

2512

97.10

 16:27:16

LSE

3979

97.10

 16:27:18

LSE

3632

97.10

 16:27:18

LSE

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZMLVGGZZM
Date   Source Headline
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration
18th Oct 20182:00 pmRNSAmgen invests £50m in Oxford Nanopore Technologies
15th Oct 20187:00 amRNSPortfolio co Garrison completes £22.9m financing
8th Oct 20187:07 amRNSPortfolio co Diurnal headline data for Chronocort
19th Sep 20189:51 amRNSDirector/PDMR Shareholding
17th Sep 20184:58 pmRNSDirector/PDMR Shareholding
17th Sep 20184:38 pmRNSDirector/PDMR Shareholding
17th Sep 201812:12 pmRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSAppointment of Chairman; Board changes
31st Aug 20189:55 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSGenomics announces Vertex leads £25m financing
29th Aug 20186:29 pmRNSIP Group plc -SAYE scheme
21st Aug 20187:06 amRNSCeres signs agreement with Bosch; £9m investment
10th Aug 20187:11 amRNSArtios Pharma completes £65m financing
31st Jul 20188:40 amRNSTR-1: NOTIFICATION
25th Jul 20187:00 amRNSHalf-yearly results
6th Jul 20187:00 amRNSNotification of Major Interest in Shares
4th Jul 20182:40 pmRNSCeres Power announces £20m fundraising
2nd Jul 20187:00 amRNSHolding(s) in Company
27th Jun 20187:30 amRNSCarisma announces $53m Series A funding round
27th Jun 20187:00 amRNSNotification of Major Interest in Shares
22nd Jun 201810:00 amRNSAppointment of Joint Broker
18th Jun 20181:37 pmRNSResult of AGM
7th Jun 20186:00 pmRNSHolding(s) in Company
6th Jun 20189:26 amRNSMicrobiotica signs collaboration worth up to $534m
16th May 201810:49 amRNSPortfolio co Ceres partners with Weichai Power
16th May 20187:00 amRNSNotice of AGM; Annual Report
11th May 20187:00 amRNSDirector/PDMR Shareholding
10th May 20186:18 pmRNSDirector/PDMR Shareholding
9th May 20185:31 pmRNSDirector share purchase
4th May 20187:00 amRNSBoard changes
30th Apr 20187:00 amRNSTotal Voting Rights
16th Apr 20185:45 pmRNSDirector/PDMR Shareholding
12th Apr 20189:19 amRNSEnterprise Therapeutics raises £29m
5th Apr 20181:12 pmRNSIP Group plc - Issue of Equity
4th Apr 201811:46 amRNSIP Group plc - Director/PDMR share purchase
29th Mar 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSOxford Nanopore announces £100m fundraising
17th Jan 201811:53 amRNSHolding(s) in Company
10th Jan 20189:12 amRNSHolding(s) in Company
2nd Jan 20187:00 amRNSTotal Voting Rights
18th Dec 201710:15 amRNSAutifony signs Eur627.5m agreement with BI
15th Dec 201712:50 pmRNSDiurnal receives positive CHMP opinion for Alkindi
14th Dec 20174:48 pmRNSDirectorate Change
13th Dec 20172:27 pmRNSIssue of Equity
8th Dec 20177:05 amRNSMirriad raises £26.2m; proposed admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.